These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Pyoderma gangrenosum caused by secukinumab successfully treated with risankizumab: a case report and literature review. Orita A; Hoshina D; Hirosaki K Clin Exp Dermatol; 2022 Jul; 47(7):1372-1374. PubMed ID: 35298047 [TBL] [Abstract][Full Text] [Related]
27. Severe recalcitrant pyoderma gangrenosum treated with infliximab. Kaur MR; Lewis HM Br J Dermatol; 2005 Sep; 153(3):689-91. PubMed ID: 16120178 [No Abstract] [Full Text] [Related]
28. Infliximab for the treatment of disseminated pyoderma gangrenosum associated with ulcerative colitis. Case report and literature review. Juillerat P; Christen-Zäch S; Troillet FX; Gallot-Lavallée S; Pannizzon RG; Michetti P Dermatology; 2007; 215(3):245-51. PubMed ID: 17823524 [TBL] [Abstract][Full Text] [Related]
29. [Pyoderma gangrenosum associated with hidradenitis suppurativa: a case report and review of the literature]. García-Rabasco AE; Esteve-Martínez A; Zaragoza-Ninet V; Sánchez-Carazo JL; Alegre-de-Miquel V Actas Dermosifiliogr; 2010 Oct; 101(8):717-21. PubMed ID: 20965015 [TBL] [Abstract][Full Text] [Related]
30. Pyoderma gangrenosum in an infant: A case report and review of the literature. Crouse L; McShane D; Morrell DS; Wu EY Pediatr Dermatol; 2018 Sep; 35(5):e257-e261. PubMed ID: 29656404 [TBL] [Abstract][Full Text] [Related]